University of Florida Dental School and Medical School
Members of GeneEx’s Science Advisory Board are on the research and clinical staff of these schools which is expected to keep the company engaged with cutting edge research in the dental and diabetes market.

Synogen Development Group, LLC
Synogen Development Group, LLC (Synogen) is an early-stage investor in GeneEx. Synogen partners with select early-stage biotech and med-tech companies, providing seed-stage financing as well as assistance in regulatory affairs, intellectual property issues, strategic planning, financial forecasting, market research and management. With more than 20 associates who are experts in their fields, they bring many years of experience and success in medical technology development and commercialization. Synogen’s focus is on bringing technologies to market rapidly, gaining regulatory approval quickly, and producing profitable operations at the earliest stage possible in company development.

BioQuest Corporation
BioQuest is a biotechnology development firm specializing in cost effective strategic planning, development and commercialization of Biopharmaceutical and Biomedical products and devices. GeneEx has engaged them because they experts in the FDA regulatory process and product development.